In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review
The coronavirus disease 2019 (COVID-19) is a severe worldwide pandemic. Due to the emergence of various SARS-CoV-2 variants and the presence of only one Food and Drug Administration (FDA) approved anti-COVID-19 drug (remdesivir), the disease remains a mindboggling global public health problem. Devel...
Saved in:
| Main Author: | Okello Harrison Onyango |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Advances in Pharmacological and Pharmaceutical Sciences |
| Online Access: | http://dx.doi.org/10.1155/2023/4562974 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Exploration of Natural Antioxidants for Sepsis Drug Discovery
by: Celia María Curieses Andrés, et al.
Published: (2025-05-01) -
In silico discovery of potential novel anti-tuberculosis drug candidates from phytoconstituents of Chlorophytum borivilianum and Asparagus racemosus
by: Munir Ibrahim, et al.
Published: (2025-02-01) -
Discovery of potent anti-toxoplasmosis drugs from secondary metabolites in Citrus limon (lemon) leaves, supported in-silico study
by: Magdy Mostafa Desoky Mohammed, et al.
Published: (2025-01-01) -
Strategies for in Silico Drug Discovery to Modulate Macromolecular Interactions Altered by Mutations
by: Pitambar Poudel, et al.
Published: (2025-04-01) -
GSFM: A genome-scale functional module transformation to represent drug efficacy for in silico drug discovery
by: Saisai Tian, et al.
Published: (2025-01-01)